Outcomes of ECLS-SHOCK Eligibility Criteria Applied to a Real-World Cohort

Background: Cardiogenic shock (CS) exhibits high (~50%) in-hospital mortality. The recently published Extracorporeal life Support in Cardiogenic Shock (ECLS-SHOCK) trial demonstrated the neutral effects of the use of veno-arterial extracorporeal membrane oxygenation (VA-ECMO) on all-cause death, as...

Descripción completa

Detalles Bibliográficos
Autores principales: von Lewinski, Dirk, Herold, Lukas, Bachl, Eva, Bugger, Heiko, Glantschnig, Theresa, Kolesnik, Ewald, Verheyen, Nicolas, Benedikt, Martin, Wallner, Markus, von Lewinski, Friederike, Schmidt, Albrecht, Harb, Stefan, Ablasser, Klemens, Sacherer, Michael, Scherr, Daniel, Manninger-Wünscher, Martin, Pätzold, Sascha, Gollmer, Johannes, Zirlik, Andreas, Toth, Gabor G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672386/
https://www.ncbi.nlm.nih.gov/pubmed/38002602
http://dx.doi.org/10.3390/jcm12226988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672386/
https://www.ncbi.nlm.nih.gov/pubmed/38002602
http://dx.doi.org/10.3390/jcm12226988

Ejemplares similares